XML 43 R37.htm IDEA: XBRL DOCUMENT v3.24.4
Fair Value Measurements (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2024
Apr. 30, 2023
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Feb. 29, 2024
Subsidiary, Sale of Stock [Line Items]                  
Note discount rate           5200.00%      
Principle amount of issued debt   $ 25,000              
Warrants outstanding       5,467,692   5,467,692   6,854,309  
(Gain) loss on derivative liability       $ (18,108) $ (4,245) $ (2,367) $ 1,090    
Common stock upon conversation of cash           $ 3,000      
Discount rate of FDA       9.30%   9.30%      
Development Milestone Payment           $ 200   $ 200  
Derivative warrant liabilities           11,500      
Warrants [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
(Gain) loss on derivative liability       $ 18,100 $ 4,200 2,400 $ 1,100    
Warrants exercised price                 $ 2.125
Oramed Note [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Estimated fair value       69,900   69,900      
Principle amount of issued debt $ 10,000   $ 101,900            
Change in fair value due to credit risk       3,200   5,000      
Change in fair value of debt and liability instruments       600   7,600      
FSF Deposit                  
Subsidiary, Sale of Stock [Line Items]                  
Estimated fair value       14,700   14,700      
Change in fair value of debt and liability instruments       $ 3,000   $ 4,700      
Private Placement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Warrants outstanding       1,000,000   1,000,000      
Firm Warrants[Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Warrants outstanding       5,568,153   5,568,153      
RDO Common Warrants [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Warrants outstanding       15,000,000   15,000,000      
Representative Warrants Outstanding[Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Warrants outstanding       470,588   470,588      
Warrant Transfer Agreement [Member] | Warrants [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Warrants outstanding       1,000,000   1,000,000   3,613,383  
Warrants exercised price       $ 0.01   $ 0.01